| NO. | Product Name | Indications | Pharmacopeia | DMF | GMP |
|---|---|---|---|---|---|
| 1 | Zoledronic Acid | Anti-tumor | - | available | NMPA (Y20190000048) |
| 2 | Anastrazole | Anti-tumor | - | available | NMPA (Y20180001226) |
| 3 | Irinotecan hydrochloride | Anti-tumor | - | available | NMPA (Y20170001143) |
| 4 | Carmustine | Anti-tumor | - | available | NMPA (Y20190000412) |
| 5 | Clofarabine | Anti-tumor | - | available | NMPA (Y20190000716) |
| 6 | Thiotepa | Anti-tumor | - | available | NMPA (Y20190000642) |
| 7 | Pomalidomide Form A | Anti-tumor | - | available | NMPA (Y20190000475) |
| 8 | Imatinib Mesylate Beta | Anti-tumor | - | available | NMPA (Y20180001570) |
| 9 | Imatinib Mesylate | Anti-tumor | - | available | NMPA (Y20170000500) |
| 10 | Gefitinib | Anti-tumor | - | available | NMPA (Y20170001213) |
| 11 | Erlotinib Hydrochloride | Anti-tumor | - | available | NMPA (Y20190021519) |
| 12 | Carfilzomib | Anti-tumor | - | available | NMPA (Y20190000413) |
| 13 | Cabazitaxel | Anti-tumor | - | available | NMPA (Y20200000296) |
| 14 | Bortezomib | Anti-tumor | - | available | NMPA (Y20180001291) |
API Domestic Sales
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Anti-tumor
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. 以下表格建议使用AI工具按品名的字母排序，以优化搜索体验功能。
| NO. | Product Name | Indications | Pharmacopeia | DMF | GMP |
|---|---|---|---|---|---|
| 1 | Abiraterone Acetate | Anti-tumor | - | available | NMPA (Y20190021377) |
| 2 | Anastrazole | Anti-tumor | - | not available | NMPA (Y20180001226) |
| 3 | Azacitidine | - | available | NMPA (Y20190000444) | |
| 4 | Bortezomib | Anti-tumor | - | available | NMPA (Y20180001291) |
| 5 | Cabazitaxel | Anti-tumor | - | available | NMPA (Y20200000296) |
| 6 | Capecitabine | Anti-tumor | - | available | NMPA (Y20170000165、Y20170000010) |
| 7 | Carfilzomib | Anti-tumor | - | available | NMPA (Y20190000413) |
| 8 | Carmustine | Anti-tumor | - | available | NMPA (Y20190000412) |
| 9 | Clofarabine | Anti-tumor | - | available | NMPA (Y20190000716) |
| 10 | Erlotinib Hydrochloride | Anti-tumor | - | available | NMPA (Y20190021519) |
| 11 | Gefitinib | Anti-tumor | - | available | NMPA (Y20170001213) |
| 12 | Gemcitabine HCl | - | available | NMPA (Y20180001569、Y20180000098) | |
| 13 | Imatinib Mesylate | Anti-tumor | - | available | NMPA (Y20170000500) |
| 14 | Imatinib Mesylate Beta | Anti-tumor | - | not available | NMPA (Y20180001570) |
| 15 | Irinotecan hydrochloride | Anti-tumor | - | not available | NMPA (Y20170001143) |
| 16 | Pomalidomide Form A | Anti-tumor | - | available | NMPA (Y20190000475) |
| 17 | Thiotepa | Anti-tumor | - | available | NMPA (Y20190000642) |
| 18 | Zoledronic Acid | Anti-tumor | - | not available | NMPA (Y20190000048) |